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Abstract: Hepatitis E virus (HEV) is a major cause of viral hepatitis globally. Zoonotic HEV is
an important cause of chronic hepatitis in immunocompromised patients. The rapid identification of
novel HEV variants and accumulating sequence information has prompted significant changes in
taxonomy of the family Hepeviridae. This family includes two genera: Orthohepevirus, which infects
terrestrial vertebrates, and Piscihepevirus, which infects fish. Within Orthohepevirus, there are four
species, A–D, with widely differing host range. Orthohepevirus A contains the HEV variants
infecting humans and its significance continues to expand with new clinical information. We now
recognize eight genotypes within Orthohepevirus A: HEV1 and HEV2, restricted to humans; HEV3,
which circulates among humans, swine, rabbits, deer and mongooses; HEV4, which circulates
between humans and swine; HEV5 and HEV6, which are found in wild boars; and HEV7 and HEV8,
which were recently identified in dromedary and Bactrian camels, respectively. HEV7 is an example
of a novel genotype that was found to have significance to human health shortly after discovery.
In this review, we summarize recent developments in HEV molecular taxonomy, epidemiology and
evolution and describe the discovery of novel camel HEV genotypes as an illustrative example of the
changes in this field.
Keywords: hepatitis E; zoonosis; hepatitis; taxonomy; molecular evolution; molecular epidemiology;
genotypes; dromedary camel; Bactrian camel; swine
1. Introduction
Hepatitis E virus (HEV) is an important cause of both epidemic and sporadic viral hepatitis.
HEV has been estimated to cause 3.3 million symptomatic cases of acute hepatitis worldwide [1] and in
some areas has overtaken hepatitis A as the most common cause of acute viral hepatitis [2]. Although
most cases are self-limiting, pregnant women, in particular, have a propensity to progress to fulminant
hepatitis [3]. Furthermore, immunocompromised patients such as transplant recipients, patients with
hematological malignancies and advanced HIV may progress to chronic hepatitis following an HEV
infection [4–6].
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The global distribution of human disease due to HEV relies partly on its “two-faced” epidemiology.
In hyperendemic areas, hepatitis E is often linked to contamination of water supplies with human
fecal material and represents person-to-person transmission [7]. However, in low endemic areas with
high socioeconomic development, hepatitis E is predominantly a foodborne zoonosis, which is most
commonly transmitted to humans consuming undercooked pork products [7,8]. In addition to pork,
hepatitis E has also been transmitted to humans consuming meat or milk of feral animals including
wild boar, deer, rabbits and camels [9–13].
The basis for this contrasting epidemiology lies in the phylogenetic diversity of HEV.
Our knowledge of HEV diversity is constantly evolving with the discovery of novel HEV variants in
various animal hosts around the world. With the accumulation of high-quality genomic information,
HEV taxonomy has undergone significant changes recently to reflect the diversity of this family of
viruses. Sophisticated sequence analyses have been possible to address various questions related to
the molecular epidemiology and evolution of HEV. The objective of this review is to provide an update
on the molecular basis of modern HEV taxonomy along with a summary of recent advances in HEV
epidemiology and evolution. The discovery of camelid HEV genotypes and recognition of their
importance to human health is used as an illustrative example of recent changes in this field.
2. HEV Genomic Organization
HEV is a nonenveloped virus with a 27–34 nm, T = 1 icosahedral capsid enclosing the viral
genome. The single-stranded, positive-sense RNA genome varies from 6.6 to 7.3 kB in length;
similar to eukaryotic mRNA, the 5′ end has a 7-methylguanylate (m7G) cap while the 3′ end is
polyadenylated [14]. Short untranslated regions flank three open reading frames (ORFs), which are
named ORF1, ORF2 and ORF3 in a 5′→3′ direction. Overlapping reading frames ORF2 and ORF3
encode for frameshifted products from a bicistronic subgenomic mRNA species [15]. There is
inter-species variation in the location of the ORF2/ORF3 junction with the divergent variant cutthroat
trout virus having an ORF3 that is displaced towards the middle of ORF2 (Figure 1).
ORF1 is the longest of the three reading frames, accounting for nearly two-thirds of the entire
genome [14]. It encodes a non-structural polyprotein that possesses several functional domains critical
for viral replication [16]. There is still controversy regarding whether the ORF1 product undergoes any
post-translational proteolytic processing [17]. Functionally characterized domains of ORF1 include
a methyltransferase, helicase and RNA-dependent RNA polymerase (RdRp). Computational analysis
of ORF1 also reveals a papain-like cysteine protease, macro and hypervariable domains. The exact role
of these domains in the HEV replication cycle remains speculative and may indirectly be inferred by
homologous domains in other positive-sense RNA viruses [16].
The ORF2 region on the 2.2 kB m7G capped subgenomic RNA (sgRNA) species encodes the
viral capsid protein, which is important for viral entry and also contains immunological epitopes for
antibody targets [17]. The ORF3 region is also expressed from the same sgRNA species and the start
codons of ORF2 and ORF3 are only separated by only a few nucleotides [14]. The ORF3 encoded
phosphoprotein has been observed to interact with the cellular cytoskeleton and endosomal system
and is tentatively believed to play a role in viral egress [18,19].
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Figure 1. Predicted genomic organization of HEV-1 to HEV-8, considering the reading frame of ORF1 
as frame 1. Reading frames of ORF2 and ORF3 are labeled relative to ORF1 reading frame. HEV-1 
(M73218); HEV-2 (M74506); HEV-3 (AP003430); HEV-4 (AJ272108); HEV-5 (AB573435); HEV-6 
(AB602441); HEV-7 strain DcHEV-178C (KJ496143); HEV-7 strain DcHEV-180C (KJ496144), HEV-8 
(KX387865). 
3. Hepatitis E Virus (HEV) Taxonomy: In Constant Evolution 
HEV is difficult to culture from clinical specimens, animal models are not widely available and 
several HEV variants from diverse epidemiological sources appear to have broadly cross-reactive 
antigenicity [20–23]. Therefore, from an early stage, the genetic characteristics of HEV variants were 
the main basis for taxonomic classification as opposed to other viral families where serotyping and 
cell culture characteristics played an important role in early classification schema. Classifications of 
HEV using genetic methods also closely mirror ecology and zooepidemiology of virus variants 
proving the fundamental soundness of this technique. However, as more sequence information from 
divergent isolates became available, there was considerable confusion due to the proliferation of 
differing classification schemes based on methods such as nucleotide identities, genetic distances, 
amino acid identities, phylogenetic analysis, PCR-restriction fragment length polymorphism, and ORF 
Figure 1. Predicted genomic organizati n of HEV-1 to HEV-8, considering the reading frame of
ORF1 as frame 1. Reading frames of ORF2 and ORF3 are labeled relative to ORF1 re ding frame.
HEV- (M73218); HEV-2 (M74506); HEV- (AP003430); HEV-4 (AJ272108); HEV-5 (AB573435);
HEV-6 (AB602441); HEV-7 strain DcHEV-178C (KJ496143); HEV-7 strain DcHEV-180C (KJ496144),
HEV-8 (KX387865).
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differing classification schemes based on methods such as nucleotide identities, genetic distances,
amino acid identities, phylogenetic analysis, PCR-restriction fragment length polymorphism, and ORF
structure of different areas of the genome [24–31]. Indeed, the very definition of various taxons within
Hepeviridae has undergone continuous evolution to reflect the emerging diversity of the family.
Originally included as a member of the family Caliciviridae, HEV was reassigned to the
newly-created family Hepeviridae in 2009 by the International Committee on Taxonomy of Viruses
(ICTV). According to the current taxonomy release (2015), the family Hepeviridae includes two
genera: Orthohepevirus and Piscihepevirus [32]. The former encompasses all mammalian and avian
HEV variants while the latter includes the highly divergent cutthroat trout virus placed within a single
species. The Orthohepevirus genus is further subdivided into four species (A–D). The current consensus
proposals for classification of the family Hepeviridae adopted by ICTV were put forward by Smith et al.
in 2014 [27,32].
Division of the family into the two aforementioned genera was made straightforward by the
clear genetic differences of Piscihepevirus A, the sole species within the Piscihepevirus genus, from
other HEV belonging to the Orthohepevirus genus: ORF3 of cutthroat trout virus (the only virus within
the Piscihepevirus genus so far) is displaced far towards the middle of ORF2 (Figure 1) compared to
members of the Orthohepevirus genus, and comparative inter-genus p-distances of even functionally
significant (i.e., highly conserved) amino acid sequences encoded by ORF1 like methyltrasferase,
helicase and polymerase exceed 0.55 [27,33]. Furthermore, overall sequence identities of ORF2 and
ORF3 between cutthroat trout virus and other members of the Hepeviridae family are only 18–21%
and 13-16%, respectively. In comparison, amino acid sequence similarities of ORF2 and ORF3 between
avian and mammalian HEV in the Orthohepevirus genus are 42-55% and 20-29%, respectively [27].
Table 1 also illustrates other differences in genomic organization between cutthroat trout virus and
other HEV types with reference to the newly discovered HEV8 camelid genotype. This extreme
phylogenetic divergence is reflected in the ecology of Piscihepevirus, which infects fish, in contrast to
other members of the family Hepeviridae, which infect terrestrial vertebrates.
Table 1. Comparison of nucleotide and deduced amino acid sequence identities of the most recently
discovered genotype, HEV-8 (BcHEV-48XJ), and other genotypes of HEV *.
HEV Genotypes/Strains (GenBank Accession No.) HEV-8 Strain BcHEV-48XJ (KX387866)
Nucleotide Identity (%) Amino Acid Identity (%)
Entire Genome ORF1 ORF2 ORF3 ORF1 ORF2 ORF3
Orthohepevirus A
HEV-1
Human HEV subtype 1a (M73218) 73.7 71.9 76.9 84.4 81.2 89.8 74.0
Human HEV subtype 1b (D11092) 73.8 71.8 77.2 84.1 81.1 90.0 74.0
Human HEV subtype 1b (L08816) 73.4 71.8 76.9 84.1 81.2 89.7 73.2
Human HEV subtype 1c (X98292) 73.7 71.6 77.4 84.1 81.5 89.5 75.6
Human HEV subtype 1d (AY230202) 74.3 72.1 78.4 84.7 81.6 90.2 74.0
Human HEV subtype 1e (AY204877) † 73.4 71.6 77.6 84.4 79.8 90.2 74.0
Human HEV subtype 1f (JF443721) 73.8 71.7 77.8 79.9 81.0 90.3 80.7
HEV-2
Human HEV subtype 2a (M74506) † 73.2 72 76.1 84.1 80.4 88.3 74.0
HEV-3
Mongoose HEV subtype 3a (AB591734) 75.8 74.2 78.5 85.9 85.7 93.0 71.3
Swine HEV subtype 3a (AF082843) 74.8 73.6 77.8 84.0 85.5 92.1 70.5
Wild deer HEV subtype 3b (AB189071) 75.3 73.9 78.5 84.8 85.6 92.6 71.3
Human HEV subtype 3b (AP003430) 75.3 73.6 78.3 85.6 85.9 92.9 73.0
Wild boar HEV subtype 3c (FJ705359) 75.8 74 78.8 85.4 86.4 92.6 72.1
Swine HEV subtype 3e (AB248521) 75.4 73.7 78.4 85.9 86.0 92.4 74.6
Human HEV subtype 3f (AB369687) 75.3 74 78.2 85.9 85.9 92.9 73.8
Human HEV subtype 3f (FJ653660) 75.5 74 78.2 85.4 85.9 92.4 73.8
Swine HEV subtype 3g (AF455784) 75.7 74.3 78.1 86.2 85.6 92.9 73.8
Human HEV subtype 3h (JQ013794) † 74.6 73.1 78.1 79.1 85.3 92.6 78.8
Wild boar HEV subtype 3i (FJ998008) † 75.1 73.9 78.0 84.0 86.0 92.9 70.5
Swine HEV subtype 3j (AY115488) 75.4 73.8 78.3 84.6 85.2 92.7 70.5
Rabbit HEV subtype 3ra (FJ906895) 74.1 71.7 78.4 82.4 82.2 88.6 70.5
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Table 1. Cont.
HEV Genotypes/Strains (GenBank Accession No.) HEV-8 Strain BcHEV-48XJ (KX387866)
Nucleotide Identity (%) Amino Acid Identity (%)
Entire Genome ORF1 ORF2 ORF3 ORF1 ORF2 ORF3
HEV-4
Human HEV subtype 4a (AB197673) 74.7 72.7 79.5 79.7 83.5 91.1 75.4
Swine HEV subtype 4b (DQ279091) 74.8 72.4 80.4 80.2 83.4 90.7 74.6
Human HEV subtype 4c (AB074915) 75.4 73.3 81.1 79.7 83.6 90.5 75.4
Human HEV subtype 4d (AJ272108) 75 73.2 79.3 77.5 83.6 88.9 70.2
Swine HEV subtype 4e (AY723745) 75.8 73.7 80.7 81.3 83.4 91.4 74.6
Human HEV subtype 4f (AB220974) 75.2 73.1 80.3 81.8 83.4 90.7 77.2
Human HEV subtype 4g (AB108537) 75.3 73.5 81.3 81.3 84.2 90.8 76.3
Swine HEV subtype 4h (GU119961) 75.2 73.1 79.9 79.9 82.7 90.1 76.3
Swine HEV subtype 4i (DQ450072) 75.5 73.2 80.0 87.0 82.7 92.4 73.0
HEV-5
Wild boar HEV subtype 5a (AB573435) 74.4 72.4 79.4 75.3 82.1 87.8 72.6
HEV-6
Wild boar HEV 6 (AB856243) 74.1 72.1 78.1 77.8 82.0 90.3 75.2
Wild boar HEV subtype 6a (AB602441) 74.5 73.2 76.5 77.5 81.3 89.8 73.7
HEV-7
DcHEV 7 (KJ496144) 75.9 74 79.1 81.3 85.9 91.4 83.2
Human HEV 7 (KT818608) † 73.4 74.5 69.2 NA 85.9 82.1 NA
DcHEV subtype 7a (KJ496143) 75.6 73.8 78.8 81.0 85.5 91.2 84.1
HEV-8
BcHEV-62XJ (KX387867) 98.3 98.2 98.8 99.7 98.8 99.7 100.0
BcHEV-12XJ (KX387865) 96.3 96.1 97.0 97.8 98.0 99.2 99.1
Orthohepevirus B
Avian HEV genotype 2 (AY535004) 52.9 52.8 51.6 42.3 43.2 44.8 24.8
Orthohepevirus C
Germany rat HEV (GU345042) 57.1 56 59.9 54.2 49.8 55.1 27.4
Vietnam rat HEV (JX120573) 56.3 55.2 58.9 51.6 50.0 55.5 29.6
Ferret HEV (JN998606) 56.2 54.7 60.5 49.5 50.5 55.9 26.5
Orthohepevirus D
Germany bat HEV (JQ001749) 53.5 53 54.8 47.0 43.7 47.3 22.9
Piscihepevirus A
Cutthroat trout HEV (HQ731075) 48.1 48.5 47.9 37.4 28.4 20.2 15.5
* HEV, hepatitis E virus; BcHEV, HEV from Bactrian camel; DcHEV, HEV from dromedary camel; NA, not available
because of incomplete genome. † Near-complete genome.
4. Beyond the Species Level: HEV Genotypes and Subgenotypes
Classification below the species level is beyond the aegis of ICTV; however, guidance on further
classification into genotypes have also been proposed by Smith et al. [27]. Much of these classification
efforts have focused on Orthohepevirus A, which is the most diverse species and contains several
genotypes pathogenic to humans. Based on pairwise amino acid sequence comparisons of available
concatenated ORF1 and ORF2 sequences (excluding the ORF1 hypervariable region) of HEV variants
visualized using a p-distance frequency distribution histogram, a p-distance of 0.088 appears to mark
the demarcation between intra-genotypic and inter-genotypic sequence diversity [27]. A p-distance
greater than this threshold is, therefore, used as the definition of novel genotypes and this system
enables classification of Orthohepevirus A into eight genotypes. However, the significant sequence
diversity within this species appears to be a continuum and the future discovery of variants that
challenge fixed definitions of genotype can be anticipated. The identification of inter-genotypic HEV
recombinants infecting swine [31,34] further complicates precise genotype allocations of all strains.
Individual genotypes within Orthohepevirus A are often congruent with well-defined geographical
distribution and host restriction although inter-species transmission of particular HEV genotypes has
been well documented in both laboratory and field settings [35]. Genotypes 1–4 are most commonly
implicated in human infection with contrasting epidemiology. Genotype 1 HEV (HEV-1) only infects
humans and is the most common cause of hepatitis E in regions with lower socioeconomic development
where it is predominantly spread via contaminated potable water. Genotype 2 HEV (HEV-2) appears
to be very rare, the only complete genome sequence comes from a strain identified in Mexico;
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based on short fragments, some HEV variants identified in Africa may belong to HEV-2 as well [36,37].
HEV-3 and HEV-4 circulate in swine populations (including pigs and wild boar) and are an important
cause of zoonotic foodborne autochthonous human hepatitis E in areas with high socioeconomic
development [38]. HEV-3 is enzootic in the Americas, Europe and parts of Asia while HEV-4 is
enzootic in China and Korea and is emerging as the major cause of human hepatitis E in the region,
outcompeting HEV1 in the last decade [39–41]. HEV-5 and HEV-6 are novel genotypes identified
in Japanese wild boars [42,43] and cluster together with HEV-4 isolates on phylogenetic analysis
(Figure 2). HEV-7 and HEV-8 were identified in camels [44,45]; their discovery and characteristics are
detailed in the next section as an illustrative example of increasing recognition of Hepeviridae diversity.Int. J. Mol. Sci. 2017, 18, 869 8 of 20 
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likelihood method and the optimal substitution model of JTT + G + I was used. In total, 2282 acid 
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M73218) were included in the analyses. The scale bar indicates the estimated number of substitutions 
per 20 amino acids. GenBank accession numbers are shown in brackets. 
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camelid HEV in dromedary camels (Camelus dromedarius or one-humped camels) from Dubai and 
then, in 2016, in Bactrian camels (Camelus bactrianus or two-humped camels) from Xinjiang, further 
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have been proposed as new genotypes of HEV (Table 1): HEV-7 for dromedary camel HEV (DcHEV) 
and HEV-8 for Bactrian camel HEV (BcHEV). A recent reported case of chronic HEV-7 infection in a 
liver transplant recipient who regularly consumed camel products [10] suggests the potential high 
impact to human health of novel genotypes within Orthohepevirus A. 
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Classification of the other Orthohepevirus species into genotypes has also been possible,
but intra-species diversity is more limited compared to Orthohepevirus A requiring varying definitions
of what constitutes a genotype. For example, the divergence among complete genome amino acid
sequences of avian HEV (Orthohepevirus B) is less than 6%, which is even lower than intra-genotypic
diversity in swine HEV-3 [27]. There is sufficient diversity between rodent and ferret HEV to classify
Orthohepevirus C into two genotypes while there is insufficient sequence information at this stage to
further classify bat HEV (Orthohepevirus D) [27].
For classification of individual HEV genotypes into subtypes, the initial work of Lu et al. [24] has
been expanded further by analysis of nucleotide p-distances of all available complete HEV genome
sequences and assignment of reference sequences for each subtype [46]. HEV-1 was identified to
have six subtypes divisible into two clades, HEV-3 has ten subtypes after excluding the related rabbit
HEV clade, and HEV-4 has nine subtypes [46]. Subtype assignment is complex as pairwise p-distance
variation is often a continuum within and between subtypes; this again precludes setting any fixed
demarcation definition of what constitutes a subtype. Several HEV variants still await definitive
subtype assignment based on the extant framework. It may be noted that viral subtype has not been
correlated with clinical severity or increased inter-species transmissibility [47]. Furthermore, the study
of HEV epidemiology, transmission patterns and evolution rely more on identification of clades from
sequence datasets rather than precise subtype designations of individual sequences [48,49]. However,
the importance of a well curated and labeled database of HEV complete genome or subgenomic
sequences as an aid to epidemiological research cannot be overemphasized.
5. Discovery of Camel HEV Genotypes
The recent discovery of two camelid HEV genotypes by our group is an illustrative example of
our rapidly expanding understanding of HEV ecology [44,45]. In 2014, we reported the discovery
of camelid HEV in dromedary camels (Camelus dromedarius or one-humped camels) from Dubai
and then, in 2016, in Bactrian camels (Camelus bactrianus or two-humped camels) from Xinjiang,
further expanding the mammalian host diversity of HEV. These camel HEV genomes possessed >20%
nucleotide difference to all other HEVs with complete genome sequences available and, therefore,
have been proposed as new genotypes of HEV (Table 1): HEV-7 for dromedary camel HEV (DcHEV)
and HEV-8 for Bactrian camel HEV (BcHEV). A recent reported case of chronic HEV-7 infection in
a liver transplant recipient who regularly consumed camel products [10] suggests the potential high
impact to human health of novel genotypes within Orthohepevirus A.
Complete genome sequencing was performed on two DcHEV strains (DcHEV 178C and 180C)
and three BcHEV strains (DcHEV 12XJ, 48XJ and 62XJ). The genome size of camel HEVs ranged
from 7212 to 7223 bases, with G + C content of 52.7% to 55.1% (Table 2). The camel HEV genomes
contained three major ORFs, with typical genome organization and characteristics similar to other
HEV genotypes of Orthohepevirus A (Figure 1). ORF1 polyprotein contained domains consistent with
a methyltransferase, a peptide containing a Y-domain, a papain-like cysteine protease, a peptide with
a hypervariable region (HVR), a helicase, and an RNA-dependent RNA polymerase. Conserved
sequences TLYTRTWS and RRLLXXYPDG that bound the HVR of HEV-1 to HEV-6 [42,50], but not
in HEVs of other Orthohepevirus species, were also present in camel HEVs. A conserved motif
(T/V)SGFSS(X)F(X)P immediately preceding the HVR of HEV-3 to HEV-6, but not present in HEV-1,
HEV-2 or HEVs of other Orthohepevirus species, were also present in HEV-7 and HEV-8 as VSGFSSDFAP
and TSGFSSNFSP respectively. The relative excess of proline and serine observed in the HVR of all
other HEVs was also observed for camel HEVs. For DcHEV strain 178C (HEV-7), ORF2 began at nt
5172, similar to HEV-4 to HEV-6 with an insertion of a single nucleotide (U) at nt 5146, and ended at nt
7154, encoding a capsid protein of 660 aa (Table 2; Figure 3). As for DcHEV strain 180C (HEV-7) and
the three BcHEV strains 12XJ, 48XJ and 62XJ (HEV-8), because of the lack of U insertion as in HEV-1,
HEV-2 and HEV-3, ORF2 began at nt 5171 for DcHEV strain 180C and nt 5176 for the three BcHEV
strains, also encoding a capsid protein of 660 aa. For DcHEV strain 178C (HEV-7), similar to HEV-4
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to HEV-6, ORF3 began at nt 5161 and ended at nt 5502, encoding a small phosphoprotein of 113 aa
with a multifunctional C-terminal region (Table 2; Figure 3). As for DcHEV strain 180C (HEV-7) and
the three BcHEV strains (HEV-8), due to the lack of the U insertion as in HEV1, HEV2 and HEV3,
ORF3 begain at nt 5160 for DcHEV strain 180C and nt 5165 for the three BcHEV strains (HEV-8) (Table 2;
Figure 3). The conserved cis-reactive element (UGAAUAACAUGU) located upstream of ORF2 and
ORF3 in the camel HEV strains might serve as promoter for the synthesis of the subgenomic mRNA
for these two ORFs (Figure 3). Most interestingly, the presence of a U insertion downstream to AUG2
in DcHEV strain 178C resembled those of HEV-4 to HEV-6, leading to three possible start codons
(AUG1, AUG2 or AUG4) for its ORF2 but one possible start codon for its ORF3 (AUG3), whereas
the lack of this U insertion downstream to AUG2 in DcHEV strain 180C resembled those of HEV1,
HEV2 and HEV3 and the three BcHEV strains (HEV-8), leading to only one possible start codon for
its ORF2 (AUG4) but three possible start codons for its ORF3 (AUG1, AUG2 or AUG3) (Figure 3).
The presence/absence of such a U insertion in different strains of the same HEV genotype has never
been observed in other HEV genotypes and is so far unique to DcHEV (HEV-7).


















Human HEV1a (M73218) 7194 58.1 27 1693 660 114 65
Human HEV1b (D11092) 7194 57.7 27 1693 660 123 66
Human HEV1c (X98292) 7193 57.6 26 1693 660 123 65
Human HEV1d (AY230202) 7192 57.4 25 1693 660 123 65
Human HEV1e (AY204877) § ≥7153 57.4 NA ≥1688 660 123 65
Human HEV1f (JF443721) 7194 57.7 27 1693 660 114 65
HEV-2
Human HEV2a (M74506) ‡ ≥7170 56.5 NA 1691 659 114 74
HEV-3
Human HEV3a (AB089824) 7244 55.3 25 1709 660 113 72
Swine HEV3a (AF082843) 7207 55.6 9 1708 660 122 54
Human HEV3b (AP003430) 7230 55.3 26 1703 660 122 72
Wild boar HEV3c (FJ705359) 7222 55.5 25 1703 660 122 68
Swine HEV3e (AB248521) 7225 54.7 25 1704 660 122 68
Human HEV3f (AB369687) 7214 55.5 5 1704 660 122 77
Swine HEV3g (AF455784) 7215 55.9 28 1697 660 122 76
Human HEV3h (JQ013794) § ≥7163 56.0 NA ≥1691 660 113 68
Wild boar HEV3i (FJ998008) ≥7197 55.6 NA 1703 660 122 68
Swine HEV3j (AY115488) 7242 55.4 26 1708 660 122 72
Rabbit HEV3ra (FJ906895) ‡ 7283 55.5 26 1722 660 122 71
HEV-4
Human HEV4a (AB197673) 7237 54.2 26 1706 674 114 69
Swine HEV4b (DQ279091) 7234 54.7 26 1705 674 114 69
Human HEV4c (AB074915) 7224 54.9 9 1707 674 114 70
Human HEV4d (AJ272108) 7232 54.4 25 1707 658 112 68
Swine HEV4e (AY723745) 7240 54.5 25 1707 674 114 70
Human HEV4f (AB220974) 7243 54.3 25 1707 674 114 73
Human HEV4g (AB108537) 7193 55.0 9 1706 674 114 42
Swine HEV4h (GU119961) 7240 55.1 26 1707 674 114 69
Swine HEV4i (DQ450072) 7235 55.2 26 1707 660 122 68
HEV-5
Wild boar HEV5a (AB573435) 7250 55.5 25 1708 674 112 77
HEV-6
Wild boar HEV6 (AB856243) 7247 55.6 25 1709 660 112 71
Wild boar HEV 6a (AB602441) 7246 57.0 25 1709 660 112 70
HEV-7
Human HEV7 (KT818608) § 7220 52.4 40 1698 660 113 66
DcHEV-178C (KJ496143) † 7220 55.1 39 1698 660 113 66
DcHEV-180C (KJ496144) ‡ 7219 54.4 39 1698 660 113 66
HEV-8
BcHEV-12XJ (KX387865) 7223 52.7 26 1704 660 113 65
BcHEV-48XJ (KX387866) 7223 53.0 26 1704 660 113 65
BcHEV-62XJ (KX387867) 7212 53.1 15 1704 660 113 72


















Avian HEV genotype 1 (AM943647) § ≥6627 55.1 NA ≥1531 606 87 123
Avian HEV genotype 2 (AY535004) 6654 55.5 24 1531 606 87 127
Avian HEV genotype 3 (AM943646) ≥6631 55.6 NA 1532 606 87 126
Avian HEV novel unclassified
genotype (JN997392) § ≥6543 55.7 NA ≥1515 606 87 NA
Orthohepevirus C
Germany rat HEV (GU345042) 6948 57.8 10 1636 644 102 65
Vietnam rat HEV (JX120573) 6927 56.6 10 1629 644 102 65
Ferret HEV (JN998606) 6841 53.8 12 1596 654 108 65
Orthohepevirus D
Bat HEV (JQ001749) 6767 51.8 33 1580 637 137 77
Piscihepevirus A
Cutthroat trout HEV (HQ731075) 7269 49.7 100 1707 634 225 76
* HEV, hepatitis E virus; UTR, untranslated region; ORF, open reading frame; BcHEV, HEV from Bactrian camel;
DcHEV, HEV from dromedary camel; NA, not available because of incomplete genome; † Assuming the third AUG
of ORF2 is the start codon; ‡ Assuming the third AUG of ORF3 is the start codon; § Near-complete genome.
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Figure 3. Alignment of nucleotide sequences showing potential start codons for ORF2 and ORF3 in 
HEV-1 to HEV-8. Potential start codons of ORF3 are shaded by red boxes, and those of ORF2 by blue 
boxes. The inserted U residues are indicated by open box. The stop codon of ORF1 is marked with 
asterisks. The conserved cis-reactive element with the sequence UGAAUAACAUGU is underlined, 
which might serve as promoter for the synthesis of the subgenomic mRNA for the ORF2 and ORF3. 
Figure 3. Alignment of nucleotide sequences showing potential start codons for ORF2 and ORF3 in
HEV-1 to HEV-8. Potential start codons of ORF3 are shaded by red boxes, and those of ORF2 by blue
boxes. The inserted U residues are indicated by open box. The stop codon of ORF1 is marked with
asterisks. The conserved cis-reactive element with the sequence UGAAUAACAUGU is underlined,
which might serve as promoter for the synthesis of the subgenomic mRNA for the ORF2 and ORF3.
Phylogenetic trees constructed using concatenated ORF1/ORF2 excluding the HVR (Figure 2),
ORF1 (Figure 4), ORF2 (Figure 5), ORF3 (Figure 6) and showed that the three Bactrian camel HEV
strains (HEV-8) were clustered with the two dromedary camel HEV strains (HEV-7) and the HEV-7
strain from the liver-transplant recipient with chronic hepatitis [10], and they were clustered with
different HEVs in different phylogenetic trees. For ORF1 and concatenated ORF1/ORF2 excluding
the HVR, HEV-7 and HEV-8 were clustered with HEV-3. However, they were clustered with HEV-1
and HEV-2 for ORF2 and clustered with HEV-2 for ORF3, but with low bootstrap support. Although
different regions of the camel HEV genomes may be more similar to different genotypes of HEV,
recombinational analysis performed using bootscan analysis revealed no obvious and definite site
of recombination. Amino acid distances based on the concatenated ORF1/ORF2 excluding the HVR
region of HEV-7 and HEV-8, and those of camel HEVs and the existing genotypes were≥0.1, which was
greater than the threshold (i.e., p-distance = 0.088) to demarcate inter-genotype distance [27] (Table 3),
supporting that the camel HEVs should constitute two different HEV genotypes, for which HEV-7 and
HEV-8 were proposed for DcHEV and BcHEV, respectively.
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The tree was constructed using maximum likelihood method and the optimal substitution model of 
JTT + G + I + F was used. Amino acid residues 1–1743 in ORF1, numbered with reference to GenBank 
sequence M73218, were included in the analyses. The scale bar indicates the estimated number of 
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Figure 4. Phylogenetic analyses of ORF1of HEVs within the genus Orthohepevirus (Species A to D).
The tree was constructed using maximum likelihood method and the optimal substitution model of
JTT + G + I + F was used. Amino acid residues 1–1743 in ORF1, numbered with reference to GenBank
sequence M73218, were included in the analyses. The scale bar indicates the estimated number of
substitutions per 20 amino acids. GenBank accession numbers are shown in brackets.
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Figure 5. Phylogenetic analyses of ORF2 of HEVs within the genus Orthohepevirus (Species A to D).
The tree was constructed using maximum likelihood method and the optimal substitution model of JTT
+ G + I was used. Amino acid residues 1–660 in ORF2, numbered with reference to GenBank sequence
M73218, were included in the analyses. The scale bar indicates the estimated number of substitutions
per 50 amino acids. GenBank accession numbers are s own in brackets.
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BcHEV-12XJ BcHEV-48XJ BcHEV-62XJ 
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Figure 6. Phylogenetic analyses of ORF3 of HEVs within the genus Orthohepevirus (Species A to D).
The tree was constructed using maximum likelihood method and the optimal substitution model of JTT
+ G was used. Amino acid residues 10–123 in ORF3, numbered with reference to GenBank sequence
M73218, were included in the analyses. The scale bar indicates the estimated number of substitutions
per 20 amino acids. GenBank accession numbers are s own in brackets.
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ORF1/ORF2 excluding HVR region *.




BcHEV-12XJ - 0.011 0.009
BcHEV-48XJ 0.011 - 0.006
BcHEV-62XJ 0.009 0.006 -
HEV-1
Human HEV subtype 1a (M73218) 0.143 0.143 0.141
Human HEV subtype 1b (D11092) 0.141 0.142 0.140
Human HEV subtype 1c (X98292) 0.140 0.140 0.139
Human HEV subtype 1d (AY230202) 0.139 0.138 0.136
Human HEV subtype 1f (JF443721) 0.143 0.143 0.141
HEV-2
Human HEV subtype 2a (M74506) † 0.156 0.156 0.155
HEV-3
Swine HEV subtype 3a (AF082843) 0.106 0.105 0.106
Human HEV subtype 3b (AP003430) 0.103 0.103 0.104
Wild boar HEV subtype 3c (FJ705359) 0.100 0.100 0.101
Swine HEV subtype 3e (AB248521) 0.104 0.105 0.105
Human HEV subtype 3f (AB369687) 0.105 0.105 0.105
Swine HEV subtype 3g (AF455784) 0.103 0.105 0.105
Wild boar HEV subtype 3i (FJ998008) † 0.101 0.101 0.102
Swine HEV subtype 3j (AY115488) 0.109 0.109 0.110
Rabbit HEV subtype 3ra (FJ906895) 0.132 0.133 0.132
HEV-4
Human HEV subtype 4a (AB197673) 0.122 0.121 0.120
Swine HEV subtype 4b (DQ279091) 0.124 0.121 0.120
Human HEV subtype 4c (AB074915) 0.123 0.121 0.120
Human HEV subtype 4d (AJ272108) 0.127 0.125 0.124
Swine HEV subtype 4e (AY723745) 0.120 0.119 0.119
Human HEV subtype 4f (AB220974) 0.127 0.125 0.124
Human HEV subtype 4g (AB108537) 0.121 0.119 0.118
Swine HEV subtype 4h (GU119961) 0.134 0.132 0.131
Swine HEV subtype 4i (DQ450072) 0.132 0.130 0.129
HEV-5
Wild boar HEV subtype 5a (AB573435) 0.139 0.140 0.140
HEV-6
Wild boar HEV 6 (AB856243) 0.139 0.140 0.139
Wild boar HEV subtype 6a (AB602441) 0.147 0.149 0.148
HEV-7
DcHEV 7 (KJ496144) 0.108 0.107 0.106
Human HEV 7 (KT818608) † 0.108 0.107 0.105
DcHEV subtype 7a (KJ496143) 0.110 0.109 0.108
* HEV, hepatitis E virus; BcHEV, HEV from Bactrian camel; DcHEV, HEV from dromedary camel; ORF, open reading
frame; HVR, hypervariable region; † Near-complete genome.
6. Delving into the Sequence: Recent Insights into HEV Molecular Epidemiology and Evolution
Rapidly accumulating sequence information over the last two decades has enabled new insights
into the evolution of HEV and its adaptation to new hosts. Such studies have largely focused on
HEV-1, HEV-3 and HEV-4 in view of the relative importance to human health of these HEV genotypes
and abundance of publicly available sequence information. Questions addressed include the ancient
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origins of HEV, reasons for current genotypic distribution, host restriction, zoonotic transmission,
local epidemiological trends, and potential future evolutionary trends of this family.
A recent systematic search for homologs of various HEV proteins in other viral families showed
that the HEV1 RdRp protein sequence shares greater identity with insect viruses (Alphatetraviridae)
and plant viruses (Benyviridae, Betaflexiviridae and Virgaviridae) compared to mammalian viruses [51].
However, phylogenetic analysis of the HEV ORF2 protein shows that it clusters together with members
of the family Astroviridae and is quite distant from the aforementioned RdRp-homologous viral families;
similarities in capsid crystal structure between astroviruses and HEV have also been noted lending
credence to the theory of common ancestry [52,53]. Although convergent molecular evolution of genes
encoding conserved enzymatic functions may theoretically be observed among unrelated viral families,
this intriguing contrast in structural and non-structural protein phylogeny indicates a recombination
event between the ORF1 sequence of insect/plant viruses and the ORF2 sequence of Astroviridae
ancestors to produce a hybrid Hepeviridae ancestor.
Divergence analysis of HEV1–4 suggests that the split into zoonotic and anthropotropic genotypes
occurred approximately 536 to 1344 years ago although significant underestimation due to the
limitations of evolutionary models is possible [54]. HEV-1 appears to be more recent than the zoonotic
genotypes with the estimated time to most recent common ancestor (TMRCA) of most modern lineages
of HEV-1 being ~87–199 years ago [54]. Population dynamics of HEV-1, HEV-3 and HEV-4 over the
last century have also been described linking fluctuations in effective population size to global trade,
wars, fluctuations in pork consumption, increased recognition of hepatitis E as a zoonosis and control
measures in swine [54,55].
Comparison of non-synonymous (dN) and synonymous (dS) substitutions in each codon position
of HEV genotypes 1, 3 and 4 reveals that most of the HEV genome is under purifying selection (dN < dS)
irrespective of genotype. Exceptions are the hypervariable region of ORF1 and the ORF2/ORF3
overlap region, which appear to be under positive selection, a trend that is especially prominent in the
zoonotic genotypes HEV-3 and HEV-4 [54,56]. Evolutionary rates differ between genotypes within
Orthohepevirus A; HEV-3 and HEV-4 appear to have higher substitution rates over time and fewer
conserved sites than HEV-1 across the entire genome [56]. Furthermore, codon usage bias of HEV-3
and HEV-4 ORFs tends to be lower than HEV-1 [57]. It is postulated that these findings may reflect the
need of zoonotic genotypes to adapt to multiple hosts and therefore different cell types with distinct
microenvironments and codon usage preferences. However, such host-specific adaptations at the
molecular level could not be demonstrated in experimentally infected pigs inoculated with a HEV-3f
isolate derived from a human [58]. Studies have attempted to link observed HEV sequence variations
to viral host-specificity markers and inter-species transmissibility, but functional confirmation of such
in silico analyses is still pending [59,60].
Evolutionary dynamics of HEV on a short-term local scale have been studied to explain the
pattern of locally predominant subtypes. Transregional flow of HEV-4 across provinces in China has
been demonstrated by phylogenetic and coalescent-based inference [61]. Similarly, Nakano et al. were
able to demonstrate the indigenization of European HEV-3e variants in Mie prefecture of Japan in
both humans and wild boar [62,63] probably through importation of large-race pigs from Europe
approximately fifty years ago. Similar analyses have been conducted for HEV strains sequenced in
Europe [64,65].
Intra-host viral evolution has also been recognized in immunocompromised individuals with
chronic hepatitis E infection. Analogous to other chronic viral infections [66–68], HEV in chronically
infected patients exists in the form of a cloud of closely-related variants which may potentially exhibit
quasispecies behavior. These variants likely arise due to fluctuating immunological pressures from the
host; composition of viral population tends to stabilize over time without treatment [69]. Such viral
heterogeneity may have direct clinical consequences; Kamar et al. reported neurological symptoms in
a renal transplant recipient with chronic HEV infection and identified distinct potentially neurotropic
quasispecies in the patient’s cerebrospinal fluid [70], while Lhomme and colleagues have reported that
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increased quasispecies heterogeneity in the polyproline and macro regions of ORF1 may potentially
be linked to chronic infections in immunocompromised hosts [71,72]. Viral heterogeneity is also of
importance in patients receiving ribavirin treatment. While ribavirin may have multiple mechanisms
of action including direct antiviral effects, depletion of intracellular guanosine triphosphate pools and
immunomodulatory mechanisms, the prevailing hypothesis is that it induces viral mutagenesis at a rate
beyond the error threshold pushing the population into extinction [73,74]. There is clear evidence for
increased viral heterogeneity in ribavirin treated patients assessed using next generation sequencing.
While ribavirin is the only effective antiviral available for chronic HEV infection, some patients are
observed to be treatment refractory. In such patients, viral variants with mutations in the HEV RdRp
region are selected out (e.g., G1634R, K1383N, D1384G, and K1398R) during treatment; the significance
of these mutations in determining the ribavirin resistant phenotype is uncertain due to the difficulty in
conducting in vitro studies and lack of widely accessible animal models [69,75,76].
While considerable advances have been made in the last decade towards an understanding of the
molecular evolution and epidemiology of HEV variants of clinical importance, further high-quality
complete genome sequences of other genotypes within Orthohepevirus A (including wild boar and
camelid HEV) will be required so that these genotypes may be included in analyses. This is of vital
importance due to the recent description of chronic camelid HEV infection in an immunocompromised
patient [10] and possible transmission of wild boar HEV genotypes to humans [35], which indicates
that zoonotic HEV from non-swine sources may be an emerging underestimated cause of hepatitis
in humans. Further intensive studies to elucidate inter-species transmission patterns of these novel
genotypes are required.
7. Conclusions: Future Directions
Our understanding of the diversity of the family Hepeviridae is constantly evolving. With accumulating
sequence information and discovery of novel genotypes, it is likely that taxonomic classifications
will require constant revisions to keep pace with advances. Future directions may include targeted
discovery programs looking for novel Orthohepevirus A genotypes in artiodactyls living in close
proximity with humans. Recent advances in metagenomic approaches and next-generation sequencing
could greatly streamline this process and may potentially identify novel sources and routes of
transmission. From the clinical perspective, due to the high degree of capsid structure amino
acid identity among different genotypes within Orthohepevirus A, increasing evidence for zoonotic
transmission from non-swine sources will be expected to accumulate. In particular, the importance of
camelid hepatitis E genotypes in causing human hepatitis in enzootic areas urgently requires further
study. Furthermore, constant vigilance for novel recombinants will be required. The ever-increasing
cache of genomic data and sophisticated models will be useful to address questions related to HEV
evolution and epidemiology; a preponderance of the extant data originates from Europe and East Asia,
extending their approaches to other parts of the world will enable us to capture a global perspective
and identify previously missed links. Finally, a better understanding of intra-host evolution of HEV
during human infection may enable us to predict clinical outcomes and treatment response in patients
at risk of chronic and fulminant HEV infection.
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